SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Chen Rui)
 

Sökning: WFRF:(Chen Rui) > (2020-2024) > Independent Validat...

Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects

Zhang, Ruyang (författare)
Nanjing University,Nanjing Medical University,Harvard University
Chen, Chao (författare)
Nanjing Medical University
Dong, Xuesi (författare)
Harvard University,Southeast University, Nanjing,Nanjing Medical University
visa fler...
Shen, Sipeng (författare)
Nanjing Medical University,Harvard University
Lai, Linjing (författare)
Nanjing Medical University
He, Jieyu (författare)
Nanjing Medical University
You, Dongfang (författare)
Harvard University,Nanjing Medical University
Lin, Lijuan (författare)
Harvard University,Nanjing Medical University
Zhu, Ying (författare)
Nanjing Medical University
Huang, Hui (författare)
Nanjing Medical University
Chen, Jiajin (författare)
Nanjing Medical University
Wei, Liangmin (författare)
Nanjing Medical University
Chen, Xin (författare)
Nanjing Medical University
Li, Yi (författare)
University of Michigan
Guo, Yichen (författare)
Harvard University
Duan, Weiwei (författare)
Nanjing Medical University
Liu, Liya (författare)
Ningbo University
Su, Li (författare)
Harvard University
Shafer, Andrea (författare)
Massachusetts General Hospital,Harvard University
Fleischer, Thomas (författare)
Oslo university hospital
Moksnes Bjaanæs, Maria (författare)
Oslo university hospital
Karlsson, Anna (författare)
Lund University,Lunds universitet,Medicinsk strålningsfysik, Malmö,Forskargrupper vid Lunds universitet,Medical Radiation Physics, Malmö,Lund University Research Groups
Planck, Maria (författare)
Lund University,Lunds universitet,Forskningsgrupp Lungcancer,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Research Group Lung Cancer,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments
Wang, Rui (författare)
Nanjing University,Jinling Hospital, Nanjing
Staaf, Johan (författare)
Lund University,Lunds universitet,Forskningsgrupp Lungcancer,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Research Group Lung Cancer,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments
Helland, Åslaug (författare)
University of Oslo,Oslo university hospital
Esteller, Manel (författare)
Catalan Institution for Research and Advanced Studies,Josep Carreras Leukaemia Research Institute (IJC),University of Barcelona,Spanish Center for Biomedical Research Network in Oncology (CIBERONC)
Wei, Yongyue (författare)
Nanjing Medical University,Harvard University
Chen, Feng (författare)
Nanjing Medical University
Christiani, David C. (författare)
Massachusetts General Hospital,Harvard University
visa färre...
 (creator_code:org_t)
Elsevier BV, 2020
2020
Engelska 12 s.
Ingår i: Chest. - : Elsevier BV. - 0012-3692. ; 158:2, s. 808-819
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: DNA methylation and gene expression are promising biomarkers of various cancers, including non-small cell lung cancer (NSCLC). Besides the main effects of biomarkers, the progression of complex diseases is also influenced by gene-gene (G×G) interactions. Research Question: Would screening the functional capacity of biomarkers on the basis of main effects or interactions, using multiomics data, improve the accuracy of cancer prognosis? Study Design and Methods: Biomarker screening and model validation were used to construct and validate a prognostic prediction model. NSCLC prognosis-associated biomarkers were identified on the basis of either their main effects or interactions with two types of omics data. A prognostic score incorporating epigenetic and transcriptional biomarkers, as well as clinical information, was independently validated. Results: Twenty-six pairs of biomarkers with G×G interactions and two biomarkers with main effects were significantly associated with NSCLC survival. Compared with a model using clinical information only, the accuracy of the epigenetic and transcriptional biomarker-based prognostic model, measured by area under the receiver operating characteristic curve (AUC), increased by 35.38% (95% CI, 27.09%-42.17%; P = 5.10 × 10–17) and 34.85% (95% CI, 26.33%-41.87%; P = 2.52 × 10–18) for 3- and 5-year survival, respectively, which exhibited a superior predictive ability for NSCLC survival (AUC3 year, 0.88 [95% CI, 0.83-0.93]; and AUC5 year, 0.89 [95% CI, 0.83-0.93]) in an independent Cancer Genome Atlas population. G×G interactions contributed a 65.2% and 91.3% increase in prediction accuracy for 3- and 5-year survival, respectively. Interpretation: The integration of epigenetic and transcriptional biomarkers with main effects and G×G interactions significantly improves the accuracy of prognostic prediction of early-stage NSCLC survival.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

early stage
interaction
multiomics
non-small cell lung cancer
prognostic score

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

  • Chest (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy